From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

Every drug, vaccine and diagnostic test we take has to undergo rigorous clinical testing for safety, quality and effectiveness before it can be approved by the U.S. Food and Drug Administration (FDA) ...

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo -- Nerandomilast, an investigational ...

Scientists have discovered that a promising new anticancer medicine currently in development could be made from unknown ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed ...

GRI Bio reached an interim enrollment goal for a clinical trial testing GRI-0621, a therapy targeting natural killer T-cells ...

Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, ...

Right to Try laws are being adopted and expanded throughout the country. In one state, they’ll allow healthy people to access ...

While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...